Spectral Analysis Probe to Identify Glioblastoma Cells

Stopped early

Conditions studied: Glioblastoma

In brief

This is a pilot, observational study to evaluate the intraoperative sensitivity of the Chaos Wand in detecting tumor tissue with glioblastoma disease.

Key facts

Study ID

NCT03293888

Run by

University of Oklahoma

People needed

12

Starts

2017-10-31

Expected to finish

2018-09-30

Last updated by the study team

2019-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female and over 18 years of age.
• Patients with histologically proven GBM who are newly diagnosed and eligible to undergo surgical treatment or patients who are suspected of having glioblastoma on pre-operative imaging which is subsequently confirmed by histopathology following tumor resection.
• Patients must be able to understand and willing to sign the informed consent document.

You may not qualify if…

• Patients with absence of glioblastoma.
• Patients who are not undergoing tumor resection.
• Patients who have prior brain radiotherapy
• Patients who have prior systemic chemotherapy
• Patients who are not willing to sign the informed consent and agree to participate.
• Patients who are pregnant or nursing

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.